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Background: Obtaining informed consent for participation in genomic research in low-income settings presents
specific ethical issues requiring attention. These include the challenges that arise when providing information about
unfamiliar and technical research methods, the implications of complicated infrastructure and data sharing requirements,
and the potential consequences of future research with samples and data. This study investigated researchers’ and
participants’ parents’ experiences of a consent process and understandings of a genome-wide association study of
malaria involving children aged five and under in Mali. It aimed to inform best practices in recruiting participants
into genomic research.
Methods: A qualitative rapid ethical assessment was undertaken. Fifty-five semi-structured interviews were conducted
with the parents of research participants. An additional nine semi-structured interviews were conducted with senior
research scientists, research assistants and with a member of an ethics committee. A focus group with five parents of
research participants and direct observations of four consent processes were also conducted. French and translated
English transcripts were descriptively and thematically coded using OpenCode software.
Results: Participants’ parents in the MalariaGEN study had differing understandings of the causes of malaria, the rationale
for collecting blood samples, the purposes of the study and the kinds of information the study would generate. Genomic
aspects of the research, including the gene/environment interaction underlying susceptibility or resistance to severe
malaria, proved particularly challenging to explain and understand.
Conclusions: This study identifies a number of areas to be addressed in the design of consent processes for genomic
research, some of which require careful ethical analysis. These include determining how much information should be
provided about differing aspects of the research and how best to promote understandings of genomic research. We
conclude that it is important to build capacity in the design and conduct of effective and appropriate consent processes
for genomic research in low and middle-income settings. Additionally, consideration should be given to the role of review
committees and community consultation activities in protecting the interests of participants in genomic research.
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International guidance and regulation requires that partic-
ipants give informed consent to research [1, 2]. Empirical
research demonstrates, however, that a number of issues
and difficulties can arise when seeking to ensure partici-
pants are appropriately informed about research [3-5]. In
some cases, features of the context in which research is
conducted may make consent processes particularly chal-
lenging, such as when research is conducted in emergency
situations [6] or in populations with low levels of literacy
and limited familiarity with relevant concepts [7-9]. As-
pects of specific research protocols may also prove diffi-
cult to explain: in genomic research such issues include
the unfamiliar and technical research methods, the impli-
cations for participants of the complicated infrastructure
and data sharing requirements, and potential consequences
of future research with samples and data (the nature of
which may be unknown at the time consent is sought)
[10-13]. All of these factors were relevant in a MalariaGEN
study which enrolled young children with parental consent
into a study to identify genetic factors affecting immune re-
sponses to malaria in 11 African and two Asian countries
(http://www.malariagen.net/projects/cp1).
Genomic research is a novel field and unfamiliar to
many people, particularly in low and middle income set-
tings. Despite increasing amounts of empirical research
being conducted on seeking consent to research, to date
there is still relatively little literature available on seeking
consent in low and middle income countries, specifically
in relation to genetic and genomic research [10, 12-18].
Issues about how much information about genomic
studies should be provided, and how best to do so, are
under-researched [19]. This is an important gap in the
literature given the increasing interest in genomic re-
search in low-income settings and in particular in Africa,
with initiatives such as H3Africa (www.H3Africa.org).
Against this background, this paper reports on under-
standings of a MalariaGEN study conducted in Mali. Rather
than seeking to assess parents’ rote recall of information
provided during consent processes, this study sought to
determine what understandings parents reached about the
study and factors affecting these [20]. Parents’ understand-
ings were combined with data from research staff and an
ethics committee about issues arising when seeking con-
sent to genomic research. Data were analysed with the
aim of identifying specific challenges arising when provid-
ing information about genomic research to participants
and potential best practices in addressing these.
The MalariaGEN study
The MalariaGEN network uses genomic research includ-
ing large-scale genome-wide association (GWA) studies to
identify genetic variants that are associated with resistance
or susceptibility to severe malaria [21]. The genomic dataare compared between multiple malaria-endemic sites to
explore changes in protective immune responses depend-
ing on the conditions of malaria endemicity. The network
has study sites in 11 African malaria-endemic countries,
including Mali (http://www.malariagen.net/community/
locations?destination=node%2F19).
The appropriate design and conduct of consent pro-
cesses for MalariaGEN research was carefully considered
before recruitment began [22, 23]. MalariaGEN devel-
oped a template and guidelines for obtaining consent in
consultation with researchers and ethics review committees
(http://www.malariagen.net/community/ethics-governance/
informed-consent). Each study site took the template and
adapted it to the local context before seeking ethical ap-
proval for the study. The aim of this two-stage process
was to ensure that fundamental human subject protec-
tions were preserved across all the MalariaGEN sites
recruiting participants, while ensuring that the proto-




This empirical study was conducted simultaneously at three
sites in Mali where genomic research was being conducted:
Bamako, Bandiagara and Mantéourou. Bamako is the cap-
ital of Mali with a heterogeneous population, of varying cul-
tural backgrounds and levels of education. The paediatric
cases of severe malaria recruited into the MalariaGEN
study in Bamako came from across the country as it is the
site of Mali’s only paediatric hospital. Controls for the
MalariaGEN study were recruited from the same locations
as the cases, including villages up to 150 km from Bamako.
Bandiagara is a multiethnic city located 700 km from
Bamako in the north-east of Mali and has been a research
site of the Malaria Research and Training Center (MRTC)
since 1997. The Dogon and the Fulani are the two main
ethnic groups in Bandiagara. The population has varying
levels of education. Mantéourou is a rural village located
800 km north-east of Bamako with a primarily non-literate
Dogon and Fulani population. This village has a research
site used for MalariaGEN recruitment.
Sampling
As this research aimed to examine the range and diver-
sity of experiences and understandings of recruitment
processes for a MalariaGEN study, purposive sampling
of five categories of relevant stakeholders was employed
(see Table 1). Categories of stakeholders, and their role in
the MalariaGEN consent process, are described below.
Forty seven parents of cases were interviewed and one
focus group was held with five fathers of cases. Cases were
children aged 0–5 years with severe malaria enrolled in
the MalariaGEN study. The children eligible for the
Table 1 Research participants and methods of data collection
Stakeholder Number and gender Method of data collection
Parents of cases 26 (male) Interview
21 (female)
5 (male) Focus group
Parents of controls 2 (male) Interview
6 (female)
Senior research scientists 2 (male) Interview
Research assistants - Recruitment of cases and controls, seeking consent: 2 (male) and 2 (female); Interview
- Processing samples and managing cases: 2 (female)
Ethics committee member 1 (male) Interview
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in Bamako with a life-threatening illness. They had fre-
quently been given traditional medicines and/or referred
from one or more health centres prior to arrival at the
hospital. Diagnosing the nature of the illness (severe mal-
aria) and identifying immediate priorities for treatment
were the primary focus of the clinical team and the child’s
family during admission. After a brief explanation of the
study procedure, researchers collected blood samples by
fingerpick for the diagnosis of malaria and complications
such as anemia. After diagnosis took place and eligibility to
participate in the MalariaGEN study was confirmed and
consent from parents was received, cases were enrolled in
the research and venous sampling for the MalariaGEN
study and any further diagnostic tests required took place.
Eight parents of controls were interviewed. Controls
were children who were matched in terms of age and resi-
dential location to the enrolled cases. Potential controls
were identified after the matched case had been enrolled
in the MalariaGEN study. The MalariaGEN study team
asked parents of cases to identify possible controls from
their family or neighbourhood. Controls were not ill with
malaria or other excluded conditions at the point of recruit-
ment into the MalariaGEN study. The MalariaGEN recruit-
ment process took place at controls’ homes, following
discussion with the family. The majority of controls were
informed about the study by families of cases before being
visited by the MalariaGEN study staff. At this time that this
study was conducted, many of the cases enrolled in the
study had not yet been matched with controls, and so fewer
parents of controls had been enrolled in the MalariaGEN
study and were eligible to take part in this research.
Two senior research scientists were interviewed. Senior
research scientists invited to participate in this study in-
cluded principal investigators and heads of research units
with extensive experience in genomic research and seek-
ing consent. Six research assistants were interviewed. Re-
search assistants included MalariaGEN staff responsible
for the consent processes for recruiting cases or controls,
or for processing research samples or providing care tomalaria cases. One ethics committee member from the
local committee responsible for reviewing genomic re-
search studies was interviewed for this study.
Data collection
The data collection methods for this qualitative study in-
corporated individual semi-structured interviews, a focus
group and direct observations of consent processes, as
well as collection of unpublished data including consent
forms and information sheets (see Table 1). Parents of
cases and controls were approached to take part in this
study one to two days after their children were enrolled
into the MalariaGEN study. Interviewers explained the
study to parents, discussed any questions they had and
recieved written consent from those who wished to take
part. Participants were interviewed in a confidential set-
ting by staff trained in qualitative research data collec-
tion, using the specific interview guide for each group.
While most parents were interviewed within two days of
recruitment into the MalariaGEN study, some parents of
cases were interviewed within 30 days following their re-
turn home from the hospital, during the recruitment of
matched controls. The focus group with fathers of cases
was held in Sanakoroba, 30 km from Bamako. Semi-
structured interviews with senior researchers, research
assistants, and a member of the ethics committee were
held in locations of the interviewee’s choice. There were
also four direct observations of consent processes (two
at Gabriel Touré hospital for cases and two in rural
areas for controls). For parents of cases, data collection
ceased when saturation was reached on the core topics
of relevance to the study. For the other stakeholder cat-
egories, data collection ceased when all the members of
the group who had consented to take part in the study
had been interviewed.
Five interview guides were developed (separate guides
were used for parents of cases of malaria, parents of
controls, researchers, field staff, and an ethics committee
member) [see Additional file 1]. The interview guides
were written in French. Guides used with parents of
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a local language (Bambara) by an external expert transla-
tor. Technical terms such as gene, heredity and ethnicity
were translated using a lexicon from the National Institute
of Local Languages. Interview guides were amended dur-
ing the course of the research to address novel issues iden-
tified during iterative analysis of the collected data. The
three interviewers and focus group facilitators had back-
grounds in sociology, pharmacy and medicine respectively,
and were trained in social science interview methods
before beginning data collection. Interviewers and the
focus group facilitators sought to minimize their influ-
ence on the views expressed by parents of cases and
controls [24].
The interviews with parents of cases and controls, and
the focus group were conducted in Bambara. Audio re-
cordings of the interviews and focus group were trans-
lated and transcribed in French and English. A reverse
translation from English into Bambara was made ver-
bally to ensure consistency of translation. Interviews
with researchers, field staff and a member of the ethics
committee were conducted in French, and transcribed in
French and English. The French and English transcripts
were analysed by members of the research team fluent
in Bambara, French and English and areas where the
translations were inconsistent or ambiguous were care-
fully reviewed, and informed subsequent development of
data collection materials and data analysis.
Data analysis
Data collected in this study were analysed iteratively
during data collection and novel relevant issues were in-
corporated into data collection materials as appropriate
[25]. In this exploratory study, a thematic approach to
data analysis was used to describe understandings of
participation in the MalariaGEN study [26]. Analysis was
undertaken using OpenCode software. KT and SB closely
read the French and English transcripts respectively, and
developed initial descriptive coding frameworks inde-
pendently [25]. The two descriptive coding frameworks
were compared and a common descriptive coding
framework was developed and applied. Following the
second round of deductive coding, inductive thematic
codes were collaboratively developed by KT and SB, and
refined in discussion with the other members of the re-
search team [27, 28].
Ethical considerations
The protocol was approved by the Ethics Committee of
the University of Bamako Faculty of Medicine, Pharmacy
and Dentistry of Mali, and the Oxford Tropical Research
Ethics Committee (OxTREC Reference 15 08) before the
study commenced. All participants gave their consent
before being included in the study.Results
Results of the analyses of data collected from the five
stakeholder groups are reported in this section. This sec-
tion begins by discussing views about the recruitment
processes for cases and controls. It then outlines parents’
differing understandings of the following four key inter-
related components of the research:
1. Distinguishing between research and medical care
2. Aims of the MalariaGEN study
3. Future uses of blood samples
4. Using blood samples in genomic research.
Recruitment processes
Cases were enrolled to the MalariaGEN study shortly
after arrival at the hospital, at which time their parents
or guardians often had limited interest in the consent
process because of concerns about the health of their
child. A parent of a child with severe malaria noted:
When they explained to me the contents of the paper
[the information sheet for the MalariaGEN study], I
think that we were all very anxious for the child…I
was asked whether I understood what was said, and so
that he would not have to begin again, I said I
understood very well, so he continued, and I did not
understand so well, because I saw only the health of
my child in the moment. That’s why I did not want to
ask too much. (Parent of severe case, male).
While there were informal opportunities to discuss the
research with the study staff while the child remained in
hospital for treatment, cases’ parents suggested that a
second consent process for the study would be valuable
once their child’s condition had been stabilised. A parent
of a child with severe malaria suggested:
The best moment to give the explanation to people is
when the patient is recovered… It seems to me that
one cannot enroll the child directly without giving
explanation about informed consent, which is why it is
given while the child is still ill. Therefore, in my
opinion, one should explain informed consent at the
beginning and then, when the child starts to recover,
one can go over the explanation again, so that the
parents have a chance to understand it when they are
not distressed about their child. This way they
understand it well. (Parent of severe case, male)
In contrast, recruitment of controls took place at their
homes. More time was available for explaining and dis-
cussing the research, and there was an absence of medical
conditions requiring immediate treatment. Upon arrival,
the research team typically received a warm welcome and
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case, who was a family member or neighbour of the con-
trol. Illustrating this perspective, one parent welcomed the
research team saying:
“Our parents told us all the good that you have
brought to them in Bamako, we were looking forward
your arrival, may God reward you” (Parent of control,
observed consent process).
After identification of potential controls, researchers
provided a detailed explanation about the study, based
on the information sheet and consent form, before ask-
ing if there were questions about the research. This con-
sent procedure took place in a peaceful environment
where all parties could consider the information pro-
vided and parents of controls did not have suggestions
for improving the consent process.
Distinguishing between research and medical care
As might be expected in a study in which severely ill
participants are treated for their condition at no cost,
many cases’ parents understood the primary objectives
of the MalariaGEN study to be therapeutic care and
charitable assistance to the poor. As one parent of a
child with severe malaria observed, “It is to take care
of children and to protect them.” (Parent of severe
case, female)
In such cases participation in the research was seen
primarily as an opportunity to access quality care at little
or no cost, as one father described:
When we arrived at the Gabriel Touré we found these
people, they said there is a project, if we take part, the
child will be treated free of charge…It is a way to help
the poor people…I really liked it; I agreed to join the
project. We ask them to take even more people, it will
help to fight against malaria” (Parent of severe case,
focus group participant, male).
In discussions about the purpose of the research,
health was prioritized by the parents of cases. The re-
search was often not perceived as an activity generat-
ing generalizable knowledge, but as aiming to fight
malaria in a particular patient through appropriate
diagnosis and treatment. Illustrating this perspective
one parent discussed perceived purposes of blood-
taking:
Taking blood to know if the child doesn’t have
something else, for example the child who has
pneumonia, if you give him a treatment of malaria
without analysis, the pneumonia continues its work.
(Parent of severe case, male)The recruitment of controls in the community was
also frequently perceived not as research but as a sign of
respect or a courtesy to the control’s parents, a public
health intervention, or a check of the status of the case.
Parents of severe cases described the recruitment of
controls in the following ways:
They came here, they gave medicines to some children,
and then they sent us rice (Parent of severe case, focus
group participant, male).
The work went well. This is their third time to come
and to see if the child [case] is still doing well” (Parent
of severe case, focus group participant, male).
Aims of the MalariaGEN study
Where parents of cases and controls did distinguish be-
tween research and the provision of care during the
MalariaGEN study, a range of different views were
expressed about the aims of the study. Some parents
were not clear about why the study was being con-
ducted, or described aims in general terms, such as seek-
ing novel treatments or vaccines for malaria. There are a
wide range of local views about potential environmental
and behavioral causes of malaria, and given these, other
parents described the study in terms of definitively iden-
tifying causes of malaria so that it could be better pre-
vented and treated. A few parents’ descriptions focused
on how the study might discover why some children get
malaria and others don’t (including, in some cases,
discovering inheritable characteristics which impact on
susceptibility):
They are searching a medicine to fight malaria, so it is
necessary to take child’s blood that has malaria, to find
a vaccine against malaria. (Parent of severe case, female)
They will take the child’s blood to know why she had
serious malaria, figure out if it is inherited from his
parents, or if he got it through other things such as
food, then they will go see other children in our
neighborhood to see why some children get severe malaria,
while other do not. (Parent of severe case, male)
There are some people who have the malaria in their
ethnicity while others don’t have the malaria. They
want to understand why some children develop the
malaria whereas others don’t develop it. Therefore
they will come with the vaccine to fight the malaria.
(Parent of control, female)
Future uses of blood samples
In this research context, there are many rumours that
blood collected during studies is sold, so recruiters made
very precise comments on this topic when explaining
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trols accepted that the blood collected during the study
would not be sold before receiving further explanations
about the future uses of the blood samples: “The blood is
not for sale, this is for disease diagnosis only” (Parent of
control, female).
In our research, participants were prompted to discuss
what uses they thought would be made of the blood
samples collected for the MalariaGEN study. In line with
views that children were solely receiving healthcare and
not taking part in research, some parents of cases
thought that blood was drawn by researchers solely for
diagnosis and treatment of their child. One focus group
participant commented:
My opinion is that this blood is put in the machine to
know the appropriate drug to use to treat the child’s illness
(Parent of severe case, focus group participant, male).
At the point of enrolment, the boundary between re-
search and curative medicine was by no means clear. Be-
fore enrolling a child in the MalariaGEN study, preliminary
tests were made, including a thick smear to diagnose mal-
aria, and assessment of hemoglobin and anemia. Some
cases of anemia diagnosed on arrival were transfused,
followed by a rapid improvement of the condition of the
children. For the parents of these children, the initial col-
lection of blood was seen as a crucial step to determine the
appropriate treatment for their children, which sometimes
led to the belief that all blood testing would be for the
benefit of their child. A focus group participant suggested:
Taking your child to a hospital where they will treat
him without analyzing his blood, is like throwing a
stone into the sun, you’re working blindly. That’s why I
straightforwardly accepted. (Parent of severe case, male)
Other parents of cases understood that the blood
would be used for research into malaria, as well as for
diagnosis:
“They said that the blood will not be sold, it is to know
how people die from malaria every year ” (Parent of
severe case, focus group participant, male).
“It is true that the benefit of treatment is great, but the
blood is collected for research so that one day the
disease can be eliminated from our country, this is my
way of understanding.” (Parent of severe case, focus
group participant, male).
Some parents who knew that blood would be used for
research purposes, did not feel the need to discuss this
further with researchers, “Well, I think the purpose is tobetter understand malaria, if not I do not think that they
can do something else with the blood ”(Parent of severe case,
male). Others did not express views about the future re-
search uses of the blood samples “No, they did not tell
me anything about it” (Parent of severe case, male).
While some parents of cases and of controls were com-
fortable with the concept that the blood would be tested for
multiple diseases during the research, others raised con-
cerns, the most common of which related to HIV research.
One parent of a severe case discussed this explicitly:
I have asked the doctor whether the blood will be used
for malaria research only or also for AIDS, and he told
me that it is only for malaria. I therefore told him to
take the amount of blood he wants” (Parent of severe
case, focus group participant, male).
Using blood samples for genomic research
Parents of cases and controls who discussed the use of
blood samples for research purposes were further
prompted to discuss genomic aspects of that research.
Given the complexity of the topic, views of the staff
recruiting participants were also sought, to determine
their understanding of genomics and issues arising with
discussing genomics during recruitment. The views of
both staff and parents are discussed below.
Understandings of research among research staff dif-
fered depending on the nature of their responsibilities.
Ward and field staff who were not directly involved in
the consent process did not have the same level of un-
derstanding as senior researchers and staff recruiting
participants. One research assistant noted:
“I was told that the blood sample will be used for
genomic research, but I do not know exactly what
genomics means” (Research assistant, female).
Findings from interviews with research staff and from
the direct observation of consent procedures, indicate
that staff recruiting participants had a good understand-
ing of the genomic aspects of the research as described
in the information sheet for the MalariaGEN study.
However, the translation of these concepts into language
accessible to participants (Bambara) posed significant
problems. Consequently research staff suggested that
further training and capacity development to assist in
such translation would be valuable.
During recruitment, explaining genomic aspects of the
study in an understandable manner proved challenging. Ex-
planations of the genomic component of the MalariaGEN
study were brief or sometimes absent during the verbal
consent process for enrolling cases. Additionally, some
parents of cases thought such aspects of the research were
too technical and difficult to understand, or of limited
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severe case, male).
In contrast, other participants discussed concepts of
heredity of susceptibilities to disease from parents to chil-
dren and their role in research, “the children of sick par-
ents will be fragile while those of healthy parents will resist
disease” (Parent of severe case, focus group participant,
male). Additionally, an interrelationship between genes
and susceptibility to a particular infection was mentioned
by few participants, as outlined in the following quotation:
It’s something from your ancestors, and some diseases
can be caught from genes…I think that this is all
connected to genetics. Some children come from their
mother’s side; others come from their father’s side. For
example, this child has come to the hospital three
times for severe malaria. Some of my children rarely
get sick. (Parent of severe case, male)
Parents’ understanding of relationships between genes
and malaria was further complicated by the range of
views of causes of malaria, including mosquitos, a variety
of different foods, insufficient hygiene and other envir-
onmental factors. It was not clear to some participants
how genes could interact with all these potential causes
of malaria. Parents of cases and controls illustrated this
point by noting:
They said that it was mosquitoes that cause malaria;
that if they bite someone with malaria and then bite
someone who isn’t sick, the mosquito transmits
malaria. Even when we’re talking outside at night, you
can get malaria. But here in the bush, even if you say
that people aren’t going to believe you… There is also
cold weather and when you bathe. Washing children at
night can give them malaria. (Parent of severe case, male)
Malaria is caused by mosquitoes, dirty water and not
cleaned houses. Mosquitoes live in dirty, stagnant
water. After, they bite people, that’s what gives
malaria. (Parent of control, female)
I’m not sure if we can get malaria from food, but
mother to child transmission is possible during
breastfeeding (Parent of control, female).
The role of heritable characteristics in malaria trans-
mission was complicated by views that children typically
inherited characteristics from one parent and that ma-
ternal transmission of malaria in during pregnancy and
breastfeeding was possible. Finally, a lack of clear inher-
itance patterns of resistance or susceptibility to severe
malaria led to doubt that genes had any role to play in
the severity of malarial infections:This problem of gene, I am not convinced. People get
illnesses by luck; it likes some more than others.
Myself, I grew up among people that are my parents,
but I never went to the hospital or did an injection.
But … my parents fall sick. Therefore the problem of
gene, me I do not believe. (Parent of severe case, focus
group participant, male)
You can do research and see what provokes the illness,
but problems of parents or genes, umm, I don’t say it
is false but I don’t say that I agree with that, because
the period during which the illness [malaria] arrives.
For example next to my family … this family’s children
fell sick when my children were healthy, but now my
children are sick and the others are healthy. That is
due to God, this is not a parent or a society…there are
familial diseases, hereditary disease that come by the
family, but this is not for malaria. (Parent of severe
case, male)
Discussion
In Mali, as in other African countries, efforts have been
made to develop protection for participants in research,
namely, the training of investigators, community involve-
ment, and the mandatory review of research protocols by
an independent ethics committee [29, 30]. Guidance and
regulation on research ethics requires that consent to re-
search must be appropriately informed if it is to be valid
[1, 2, 31]. While there is some consensus about core topics
that should be covered in all recruitment processes, re-
searchers are required to determine how much informa-
tion about each of these core topics should be provided,
and how to support understanding of the information on a
study by study basis [8, 32]. The limited empirical research
into developing consent processes for genomic research
suggests that promoting participants’ understanding that
they are enrolled in genetic or genomic research and the
implications of such enrollment can present challenges in a
number of African settings [10, 12-15, 17, 18].
The findings from this study confirm that determining
how much information should be provided to partici-
pants and how best to support understanding of gen-
omic research is not straightforward. Similarly to staff
recruiting MalariaGEN participants in Ghana [13], many
researchers in this study reported difficulties with explain-
ing the research in local languages, due to the lack of simi-
lar concepts in such languages. While research participants
in this study overwhelmingly reported satisfaction with
their participation in the MalariaGEN study, a number of
issues about their understandings of the study were identi-
fied. Before understanding genomic components of the re-
search, MalariaGEN participants needed to understand
that they were participating in research, that blood samples
were collected for research purposes, and that the research
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some children are more susceptible to severe malaria than
others. Even in cases where these factors were understood,
understanding of the genomic component of the research
could remain elusive. Despite receiving consistent informa-
tion about the research, parents demonstrated a range of
understandings of the above aspects of the study. The im-
plications of these differences and means of supporting un-
derstanding of each of the four aspects are discussed below.
Some parents of cases and of controls understood them-
selves to be consenting solely to healthcare. Although this
view is often termed therapeutic misconception, it could
be argued that rather than a misconception, it is a logical
interpretation of participation in this study [33, 34]. For
cases, collection of a small additional amount of blood for
research purposes may appear insignificant to parents in
the context of the lifesaving healthcare provided to their
child in a hospital ward. As such, the activity undertaken
by researchers was characterized entirely as healthcare
and its research component not singled out by parents for
separate consideration. Additionally, due to concerns
about the health of their child, many parents of cases had
limited interest in, or peace of mind to consider, informa-
tion provided about the research, and in some cases
sought to curtail the consent process.
In contrast, during recruitment of controls, there was
no pressing need for healthcare and more time to dis-
cuss the study with parents and family in a familiar set-
ting. Despite the lack of healthcare provision, and a
more in depth consent process, parents of controls were
very aware of the healthcare received by cases and some
characterized the MalariaGEN study as a public health
intervention for malaria, rather than research.
Research into therapeutic misconception demonstrates
that it is pervasive, arising in relation to multiple kinds
of research in a range of settings [35]. Even highly edu-
cated participants may have difficulties reconciling infor-
mation provided about unfamiliar research concepts
with what appears to be healthcare provided by health-
care staff [36]. Participants may also prefer to view what
is being provided as individualized care based on their
condition, rather than a standardized protocol being
assessed to provide generalizable knowledge.
In the face of these environmental cues (such as the
provision of information about research in healthcare
settings), and personal hopes, identifying the best means
of addressing therapeutic misconception about genomic
research is challenging. It is clear that simply providing
more information about the research may not be suffi-
cient to address therapeutic misconception. Measures to
improve information provision and address environmen-
tal cues in the healthcare setting, such as a two stage
consent process and having research staff wear plain
clothes in contrast to uniformed healthcare staff, provedof value in assisting parents of cases in distinguishing
between healthcare and research during MalariaGEN re-
search in Ghana [13]. However, such measures would
not have assisted the parents of controls in this case,
and further research would be valuable to determine
how to minimize therapeutic misconception during gen-
omic research in low and middle income settings.
As discussed above, when parents of cases and controls
distinguished between research and care, they reported a
range of understandings of the aim of the MalariaGEN
study. Some perspectives specifically encompassed human
genomic research, and others excluded it (such as identify-
ing environmental causes of malaria). Care is needed to
determine how best to describe the aims of research in a
comprehensible fashion, particularly when complex and
unfamiliar research methods are involved. Some discus-
sions of research aims may identify misconceptions about
the disease being studied (such as views that malaria can
be caused by oily food or transmitted by breastfeeding)
which should be addressed to enable participants to
limit their exposure to future malarial infections. In
other cases, participants may understand the aims of the
research in very general terms, such as helping to fight
against malaria, or developing treatments and vaccines.
In such cases questions arise about the extent of re-
searchers’ responsibilities to ensure that participants are
aware that the research will entail comparing individual’s
inheritable characteristics. These issues are discussed
further below.
In this and many other African contexts, taking blood
samples for research is a sensitive topic [34, 37-39].
Concerns are raised about physical and spiritual effects of
taking blood, particularly when children with severe mal-
aria have anaemia, which in local languages may be liter-
ally translated as ‘not having enough blood’ [13].
Concerns also arise about the purposes for which the
blood can be used, such as being pooled with other blood
samples for sale (particularly in contexts such as this
where blood must be purchased from the blood bank if a
donor cannot be found) or used in rituals [34]. Taking of
blood for diagnostic tests during healthcare in contrast,
may be less controversial, as the need to identify exactly
what is wrong with a sick child is widely acknowledged.
During genomic research where healthcare is also pro-
vided, care is needed to ensure that participants, or in
this case participants’ parents, are aware that some of
the blood will be taken for research purposes, and what
tests will be run with it. Particular care will be needed
where it is likely that some tests, such as HIV tests, are
likely to be of concern to participants. Some research
groups are seeking to build awareness of how blood is
used in research amongst local communities by giving
tours of research facilities and addressing misconceptions
about uses made of blood during research [15, 40]. The
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what will be done with blood samples should be reviewed
in settings where genomic research is conducted.
There are a number of potential limitations to this
study. There were varying intervals of time between par-
ents of cases’ and controls’ enrolment in the MalariaGEN
research and their participation in interviews or the focus
group for this study. In such cases reported understand-
ings might be impacted by abilities to recall information
over time, leading to participants being reported as having
less understanding of the research than they did at the
point of enrolment into the MalariaGEN study. Due to re-
cruitment of matched controls having to lag behind re-
cruitment of cases, there were fewer parents of controls
eligible to participate in this qualitative study: eight con-
sented to be interviewed and none consented to take part
in a focus group. Additionally the higher female to male
ratio in the parents of controls, when compared to parents
of cases, may have affected our findings. While additional
data from parents of controls could have been valuable in
identifying novel considerations or elements of under-
standings, data were saturated on core topics discussed
during interviews. Focus groups are a valuable data collec-
tion method when exploring understandings of a complex
topic such as genomic research and provided an oppor-
tunity to determine how participants responded to varying
views of what the MalariaGEN research entailed [41]. Five
fathers of cases kindly consented to take part in the focus
group, additional focus groups with mothers of cases and
controls, and fathers of controls could have provided fur-
ther valuable insights into how understandings of the
MalariaGEN were constructed.
An additional potential limitation of the study results
from the multiple languages used during data collection,
analysis and reporting. The research team was very aware
of the potential for meanings to be lost or misconstrued
during translation, so care was to use expert translators,
to back translate where appropriate, and to review trans-
lated transcripts in areas where meaning was not being
preserved. Discussions of some of the concepts that
proved more challenging to translate comprised a valuable
component of the analysis.
Conclusions
Genomic research is an important field of research to
understand and develop responses to endemic diseases in
the African region. The findings from this study demon-
strate that promoting understanding of the genomic nature
of research requires that there has been understanding of
multiple aspects of the study. Even where there is an inter-
est in learning about the role of inheritable characteristics
in susceptibility or resistance to severe malaria, the best
means of explaining the interaction between inheritable
characteristics and causes of disease may be difficult toidentify. This complexity is exacerbated by the difficulty of
discussing some of these concepts in local languages and
advice from experts in such languages may be of great
value in facilitating understanding of technical aspects of
the research. Capacity building to support understanding
of genomic research amongst research staff, and to sup-
port the development of methods to support understand-
ing of genomic research amongst participants, is a critical
component of future genomic studies. Such capacity
building ought also to include the development of training
and educational resources relating to practical ethics.
It should be noted that not all participants will wish to
expend significant time and effort to understand the gen-
omic nature of research, particularly if they perceive the
research to be of limited risk. In situations where under-
standing at the time of consent are likely to be imperfect,
which is the case in genomic research wherever in the
world it is conducted, important ethical questions arise re-
lating to what levels of understanding and of which core
features are required for consent to be considered ‘valid’.
For example, the findings above demonstrate that signifi-
cant amounts of background information are required to
explain the relevance of genomics in transmissible dis-
eases, where complex gene-environment interactions are
being studied and patterns of inheritance are not straight-
forward. Significant levels of understanding of the tech-
nical nature of the research will also be required if the
implications of sharing genomic data for secondary re-
search purposes are to be evaluated by participants.
Whilst the question of what comprises valid informed
consent has an empirical component and further research
such as that conducted for this study is essential, the iden-
tification of good ethical consent practice in genomics re-
search also requires careful ethical analysis and judgment.
This will include a consideration of what additional pol-
icies, practices and processes may be needed to protect
participants where research demonstrates that core aspects
of the research are often not well understood. In such cir-
cumstances, in addition to identifying best practices in in-
formation provision for research participants, further
review of the role of ethics committees and community en-
gagement mechanisms in genomic research is critical.
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